Friday 6 November 2026
Export EHC’s income statement to Excel — free account
Encompass Health Corporation
EHC Healthcare Medical Care Facilities
Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024.
- Revenue
- +8.93%
- EPS
- +20.6%
- Free cash flow
- +52.3%
- Total debt
- +6.83%
Quarter to September 2026, against a year earlier
137.30
3.97
−2.81%
Follow EHC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
18.75 | 16.25 | 15.91 | 18.85 |
+8 more quarters Free account |
P/S ratio |
1.88 | 1.61 | 1.58 | 1.80 | |
P/FCF ratio |
27.93 | 26.02 | 22.07 | 26.04 | |
P/Operating CF |
32.99 | 35.34 | 30.65 | 30.83 | |
P/B ratio |
3.41 | 2.93 | 2.90 | 3.32 | |
Price to Tangible BV |
6.36 | 5.63 | 5.68 | 6.70 | |
EV/Sales |
2.28 | 2.01 | 1.98 | 2.20 | |
EV/EBITDA |
9.45 | 8.50 | 8.38 | 9.39 | |
EV/Operating CF |
11.08 | 10.30 | 10.00 | 11.10 | |
EV/FCF |
33.77 | 32.54 | 27.61 | 31.87 | |
Quick Ratio |
0.88 | 0.94 | 0.96 | 0.86 | |
Current Ratio |
1.09 | 1.19 | 1.17 | 1.08 | |
Net Debt/EBITDA |
6.51 | 6.66 | 6.20 | 6.29 | |
Debt/Assets |
34.35% | 35.32% | 35.19% | 35.13% | |
Debt/Equity |
0.74 | 0.77 | 0.78 | 0.77 | |
Asset Turnover |
0.88 | 0.87 | 0.87 | 0.87 | |
Operating CF/Net income |
2.41 | 1.84 | 1.61 | 2.36 | |
Capex/Depreciation |
(2.45) | (2.44) | (1.86) | (2.39) | |
Interest Coverage |
8.94 | 8.70 | 9.48 | 9.38 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
59.99% | 59.41% | 59.28% | 60.47% | |
Intangible Assets out of Total Assets |
0.21 | 0.22 | 0.22 | 0.23 | |
Share Based Compensation of Revenue |
0.93% | 0.86% | 0.72% | 1.19% | |
Graham Net Nets |
(0.26) | (0.30) | (0.31) | (0.28) | |
Graham Number |
72.08 | 69.43 | 67.55 | 63.68 | |
Earnings Yield |
5.33% | 6.15% | 6.29% | 5.30% | |
Free Cash Flow Yield |
3.58% | 3.84% | 4.53% | 3.84% | |
Revenue per Share |
16.37 | 16.17 | 15.99 | 15.37 | |
Operating CF per Share |
3.68 | 2.86 | 3.16 | 3.44 | |
Capex per Share |
(2.39) | (2.23) | (1.64) | (2.28) | |
Free Cash Flow per Share |
1.30 | 0.63 | 1.52 | 1.16 | |
Cash per Share |
1.02 | 1.35 | 1.65 | 1.02 | |
Shareholders Equity per Share |
35.63 | 34.45 | 33.35 | 32.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
35.63 | 34.45 | 33.35 | 32.01 | |
Free Cash Flow |
127.50 | 62.30 | 150.70 | 116.70 | |
Working Capital |
85.60 | 167.60 | 152.30 | 69.50 | |
Capital Expenditures |
(234.50) | (220.30) | (162.40) | (229.30) | |
Net Current Asset Value |
(3,050.90) | (3,013.30) | (2,975.70) | (2,966.30) | |
EV/EBIT |
12.47 | 11.21 | 11.04 | 12.40 | |
Capex to Sales |
0.15 | 0.14 | 0.10 | 0.15 | |
Price to Operating Income |
10.31 | 8.97 | 8.82 | 10.13 | |
| Other line items | |||||
Average Receivables |
661.40 | 649.90 | 649.70 | 609.00 | |
Average Payables |
184.90 | 198.05 | 181.55 | 174.60 | |
Average Assets |
7,216.10 | 7,121.60 | 6,977.25 | 6,812.20 | |
Average Common Equity |
3,317.25 | 3,218.15 | 3,094.95 | 3,005.10 |
Columns are period end dates · fundamentals updated 5 Nov 2026